March 2010 | BioSpectrum Asia Pacific Awards 2010: Emerging company of the year: Curiox biosystems, Singapore
The pharmaceutical industry has been under increasing pressure to deliver drugs to the market faster and more efficiently. In an effort to combat this, Dr Namyong Kim, who leads a team of scientists at the Institute of Bioengineering and Nanotechnology (IBN), under the Agency for Science, Technology, and Research (A*STAR) in Singapore developed the new bioassay technology called DropArray. More»

May/June 2009 | Novel test detects eye ailments in minutes, needs less tear fluids
SINGAPORE National Eye Centre (SNEC) researchers are testing a new technology, touted for its abiwlity to accurately detect eye ailments more quickly than current
methods. More»

Dec 17, 2007 | Curiox's Mini-Bioassay Tech to Aid Cheaper Drug Development
Curiox Biosystems has developed a miniaturisation platform that enables cheaper and more efficient bioassays to be conducted, potentially slashing the costs of life science and drug discovery research. More»

Dec 17, 2007 | Nanotechnology Firm Invests in Singapore Biomedical Start-up
German nanotechnology company had decided to make a 16.5 per cent investment in a Singapore-based start up called Curiox Biosystems. Nanostart AG is widely seen as the world's leading nanotechnology investment company. More»